Russia registered the world’s first Covid-19 vaccine for animals, the Carnivac-Cov, announced the country’s agricultural regulatory agency on Wednesday (31).
Regulatory agency Rosselkhoznadzor says that the immunizer is inactivated virus and can protect vulnerable species and prevent viral mutations.
Clinical trials started in October on dogs, cats, foxes, minks and other animals and a Carnivac-Cov is recommended for carnivorous animals, segundo a Rosselkhoznadzor.
“The results of the studies allow us to conclude that the vaccine is harmless and that it is highly immunogenic, since antibodies to the coronavirus were developed in 100% of the cases,” says Konstantin Savenkov, deputy head of the Russian regulatory agency.
Yet, Russia has only documented two cases of Covid-19 among animals, both in cats, according to the Reuters news agency.
Coronavirus mutation in animals
The World Health Organization (WHO) has already expressed concern about the transmission of the virus between humans and animals.
In November, Denmark slaughtered all 17 million mink from its breeding sites, after concluding that a line of coronavirus had moved from humans to mink and the virus mutation infected 12 people.
Mink are weasel-like animals raised on farms for the manufacture of coats and other garments.
“The virus that has been mutated through mink could pose a risk that future vaccines will not work as they should. All mink must be sacrificed,” said Danish Prime Minister Mette Frederiksen at the time.
Mink are weasel-like animals raised on farms for the manufacture of coats and other fur garments – Photo: Pixabay
Russia was also the first country in the world to authorize the use of a vaccine against the new coronavirus in humans, the Sputnik V, In August. The registration was granted when the Russian vaccine was still in phase 1 testing in humans and there were no studies on its effectiveness.
Four months later, in December, the Russian research institute Gamaleya reported that the Sputnik V it was 91.6% effective against the disease, according to preliminary results published in the scientific journal “The Lancet”, one of the most respected in the world.
The Russian vaccine for humans has not yet been approved in Brazil by Anvisa (National Health Surveillance Agency). The agency received on Friday (26) a new request for emergency use of the immunizer.
Days before, Anvisa said that it needed to have access to the raw data of the company’s tests Sputnik V, a requirement for requesting emergency use in Brazil.
VIDEOS: news about vaccines against Covid-19
Get the latest news delivered to your inbox
Follow us on social media networks